These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 4790189)
1. [Permanent lymphoblastic cell cultures as model for study of action mechanism of antileukemic substances]. Wilms K; Wilmanns W Verh Dtsch Ges Inn Med; 1973; 79():1379-81. PubMed ID: 4790189 [No Abstract] [Full Text] [Related]
2. The use of long-term human leukocyte cell cultures as models for the study of antileukemic agents. Hirshaut Y; Weiss GH; Perry S Cancer Res; 1969 Sep; 29(9):1732-40. PubMed ID: 5258874 [No Abstract] [Full Text] [Related]
3. Mechanism of action of antileukemic agents and their clinical effects. Nakamura T; Tatsumi K; Higuchi T; Shirakawa S; Wakisaka G Nihon Ketsueki Gakkai Zasshi; 1974 Jun; 37(3):302-15. PubMed ID: 4479921 [No Abstract] [Full Text] [Related]
4. [Mechanism of action of antileukemic agents in leukemia chemotherapy]. Nakamura T Rinsho Ketsueki; 1996 May; 37(5):380-91. PubMed ID: 8691581 [No Abstract] [Full Text] [Related]
5. New antileukemic agents. Mantadakis E; Kalmanti M Pediatr Hematol Oncol; 2003; 20(3):173-85. PubMed ID: 12637214 [TBL] [Abstract][Full Text] [Related]
6. Prolonged survival of lymphocytes with chromosomal defects in children treated with 1,3-bis(2-chloroethyl)-1-nitrosourea. Harrod EK; Cortner JA J Natl Cancer Inst; 1968 Feb; 40(2):269-82. PubMed ID: 5237518 [No Abstract] [Full Text] [Related]
10. Changes in acetylcholinesterase (AchE) activity in lymphocytes and whole blood in acute lymphoblastic leukemia patients. Battisti V; Schetinger MR; Maders LD; Santos KF; Bagatini MD; Correa MC; Spanevello RM; do Carmo Araújo M; Morsch VM Clin Chim Acta; 2009 Apr; 402(1-2):114-8. PubMed ID: 19185568 [TBL] [Abstract][Full Text] [Related]
11. Phenothiazines suppress proliferation and induce apoptosis in cultured leukemic cells without any influence on the viability of normal lymphocytes. Phenothiazines and leukemia. Zhelev Z; Ohba H; Bakalova R; Hadjimitova V; Ishikawa M; Shinohara Y; Baba Y Cancer Chemother Pharmacol; 2004 Mar; 53(3):267-75. PubMed ID: 14663628 [TBL] [Abstract][Full Text] [Related]
17. Data mining the NCI cancer cell line compound GI(50) values: identifying quinone subtypes effective against melanoma and leukemia cell classes. Marx KA; O'Neil P; Hoffman P; Ujwal ML J Chem Inf Comput Sci; 2003; 43(5):1652-67. PubMed ID: 14502500 [TBL] [Abstract][Full Text] [Related]
18. Quercetin decreases intracellular GSH content and potentiates the apoptotic action of the antileukemic drug arsenic trioxide in human leukemia cell lines. Ramos AM; Aller P Biochem Pharmacol; 2008 May; 75(10):1912-23. PubMed ID: 18359480 [TBL] [Abstract][Full Text] [Related]
19. [Antimetabolites in the therapy of human acute leukemia. Mechanism of action and factors conditioning the cellular response to the drugs. 3. Cellular kinetics and chemotherapy]. Grignani F; Martelli M; Tonato M Clin Ter; 1974 Mar; 69(3):263-79. PubMed ID: 4846658 [No Abstract] [Full Text] [Related]
20. The discovery and development of new antileukemic drugs. Grever M; Malspeis L Hematol Oncol Clin North Am; 1993 Feb; 7(1):233-54. PubMed ID: 8449860 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]